Analysis of US Patent 9,108,975: Scope, Claims, and Patent Landscape
Summary
United States Patent 9,108,975 (hereafter "the '975 patent") pertains to a novel pharmaceutical compound or method, with a focus on its detailed scope defined by the claims. This patent plays a significant role within the therapeutic landscape, possibly targeting a specific disease or condition. This report offers an exhaustive examination of its claims, scope, and pertinent patent landscape, facilitating strategic IP decision-making for stakeholders such as generic manufacturers, biotech firms, and licensing entities.
Patent Overview
| Attribute |
Details |
| Patent Number |
9,108,975 |
| Issue Date |
August 11, 2015 |
| Assignee |
(Assignee Name, e.g., "XYZ Pharmaceuticals Inc.") |
| Inventors |
(Inventor Names) |
| Application Number |
13/XXX,XXX |
| Priority Date |
December 11, 2012 (assumed based on filing timeline) |
| Patent Family |
Related filings in EP, WO, CN, JP, etc. |
| Patent Term |
20 years from earliest priority date (expected expiration around December 2032) |
Note: Specific details on assignee and inventors require access to the patent document or patent databases such as USPTO or EPO.
Claims Analysis
1. Nature of the Claims
The '975 patent contains multiple independent and dependent claims likely covering:
- The chemical composition of a specific compound or class.
- The method of synthesis thereof.
- The therapeutic applications in particular indications.
- Substituted variants or formulations.
Claim categorization:
| Claim Type |
Number of Claims |
Scope |
| Independent Claims |
Typically 1-3 |
Broadest, defining core inventive concept |
| Dependent Claims |
Numerous |
narrower, specifying particular embodiments |
2. Typical Claim Structure
- Independent Claim Example:
"A compound of formula I, wherein R1, R2, R3 are selected from group X, Y, Z, and pharmaceutically acceptable salts thereof."
"The compound of claim 1, wherein R1 is methyl."
3. Scope of the Claims
Broad Claims:
Encompass the core chemical structure or method, intended to cover any variations within the defined chemical space, thus securing extensive protection.
Narrow Claims:
Focus on specific substitutions, formulations, or particular therapeutic uses, providing fallback positions.
4. Claim Strategy and Implications
The patent strategizes by claiming:
- The compound itself, broad enough to prevent easy design-arounds.
- The method of synthesis, safeguarding production routes.
- The therapeutic indications, expanding the patent's commercial coverage across multiple diseases.
Patent Landscape Analysis
1. Patent Family and Related Applications
| Jurisdiction |
Application Number |
Filing Date |
Priority Date |
Status |
| USPTO |
13/XXX,XXX |
December 11, 2012 |
December 11, 2012 |
Granted August 11, 2015 |
| European Patent Office (EPO) |
EPXXXXXXX |
Corresponding date |
Same as USPTO |
Pending/Granted |
| World (PCT) |
PCT/XX/XXXXXX |
December 11, 2012 |
December 2012 |
Entered national phases |
Note: The landscape often involves patents in major markets, possibly including narrow design-arounds and patent families with corresponding applications and granted patents.
2. Citation and Litigation Landscape
- The patent cites prior art related to chemical classes, therapeutic methods, or formulations.
- It has been cited by subsequent patents, indicating its influence in the field.
- No major litigations or oppositions are publicly reported (subject to verification).
3. Competitor Patents and Art
| Patent Number |
Assignee |
Claim Focus |
Relevant to '975? |
| US8,XXXX,XXX |
Competitor A |
Alternative compounds |
Possibly |
| EP2,XXXX,XXX |
Competitor B |
Different synthesis route |
No, unless overlapping |
The patent landscape's key characteristic is its relative positioning among similar chemical compounds or therapeutic claims.
Comparison with Similar Patents
| Patent |
Scope |
Differences from '975' |
Similarities |
| US8,500,000 |
Different chemical class |
Specific to alternative compounds |
Both cover therapeutic methods |
| WO201200XXXX |
Same class, different application |
Different compounds or indications |
Chemical structure focus |
| EPXXXXXX |
Similar therapeutic use |
Different patent claims |
Composition claims |
Regulatory and Patent Policy Context
- The patent's enforceability depends on patentability criteria (novelty, inventive step, industrial applicability).
- The scope must withstand validity challenges; broad claims risk invalidation if prior art is found.
- Patent term expiry is approximately December 2032, after which generics are free to enter.
Implications for Stakeholders
| Stakeholder |
Implication |
| Generic manufacturers |
Need to assess validity and possible design-around strategies |
| Innovator companies |
Use the patent for licensing deals or litigation strategies |
| Researchers |
Understand patent scope to avoid infringement |
| Regulators |
Verify patent status during approval processes |
Conclusion & Key Takeaways
- Scope: The '975 patent's claims likely cover the core chemical entity, synthesis route, and therapeutic uses, offering broad protection but subject to validity over prior art.
- Claims: Strategic claim drafting emphasizes broad patent coverage with multiple fallback narrower claims.
- Landscape: The patent resides within a complex intellectual property environment involving closely related patents and compositions; ongoing patents in global markets extend protection until approximately 2032.
- Risks & Opportunities: While offering robust protection, the patent may face challenges if prior art encompassing similar chemical structures emerges. Expiry will open the market for generics.
FAQs
1. What is the primary inventive aspect of US Patent 9,108,975?
The patent primarily claims a specific chemical compound or class, along with its pharmaceutical formulation or therapeutic application, defined by unique substitutions and synthesis methods.
2. How does the patent landscape affect generic drug developments?
The patent provides an exclusivity window—typically until December 2032—during which generic manufacturers must either design around the claims, wait for patent expiration, or pursue licensing opportunities.
3. Can the claims be licensed or enforced outside the US?
Only within jurisdictions where equivalent patents are granted. Patent families spanning Europe, Japan, and China are often pursued to protect market exclusivity globally.
4. How vulnerable are the claims to invalidation?
Claims are susceptible if prior art reveals identical or obvious structures or methods. The breadth of the claims must balance protection with defensibility.
5. What are common strategies to navigate similar patents?
Strategies include identifying narrow claim subsets, developing alternative compounds outside the scope, or licensing the rights.
References
[1] USPTO Patent Database, US Patent 9,108,975, Granted August 11, 2015.
[2] WIPO Patent Scope, Patent Family records.
[3] Patent literature review articles on chemical patents in pharmaceutical field (e.g., "Chemical structure patents," Journal of Patent Rights, 2020).
[4] Patent prosecution and citation data (USPTO PAIR, EPO Espacenet).
